Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.33
-0.36 (-2.80%)
Dec 26, 2025, 9:59 AM EST - Market open
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $359.67 million as of December 26, 2025. Its market cap has decreased by -3.77% in one year.
Market Cap
359.67M
Enterprise Value
182.61M
1-Year Change
-3.77%
Ranking
Category
Stock Price
$12.33
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $359.67M, a decrease of -10.55%. That is a compound annual growth rate of -6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 370.03M | -2.02% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |